Progress in the Understanding of the Mechanism of Tamoxifen Resistance in Breast Cancer
出版年份 2020 全文链接
标题
Progress in the Understanding of the Mechanism of Tamoxifen Resistance in Breast Cancer
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-12-10
DOI
10.3389/fphar.2020.592912
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Overcoming tamoxifen resistance in oestrogen receptor‐positive breast cancer using the novel thiosemicarbazone anti‐cancer agent, DpC
- (2020) Sundus N. Maqbool et al. BRITISH JOURNAL OF PHARMACOLOGY
- ERα36 as a Potential Therapeutic Target for Tamoxifen-Resistant Breast Cancer Cell Line Through EGFR/ERK Signaling Pathway
- (2020) Guangliang Li et al. Cancer Management and Research
- Repositioning Aspirin to Treat Lung and Breast Cancers and Overcome Acquired Resistance to Targeted Therapy
- (2020) Ling Li et al. Frontiers in Oncology
- Effect of aspirin use on neoadjuvant chemoradiotherapy for rectal cancer: a meta-analysis with trial sequential analysis
- (2020) Bolin Wang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Dying tumor cell-derived exosomal miR-194-5p potentiates survival and repopulation of tumor repopulating cells upon radiotherapy in pancreatic cancer
- (2020) Ming-jie Jiang et al. Molecular Cancer
- Aspirin‐targeted PD‐L1 in lung cancer growth inhibition
- (2020) Yixiang Zhang et al. Thoracic Cancer
- The miR-186-3p/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells
- (2019) Mengjia He et al. ONCOGENE
- Combined Targeting of Estrogen Receptor Alpha and XPO1 Prevent Akt Activation, Remodel Metabolic Pathways and Induce Autophagy to Overcome Tamoxifen Resistance
- (2019) Eylem Kulkoyluoglu-Cotul et al. Cancers
- Lactate dehydrogenase A regulates autophagy and tamoxifen resistance in breast cancer
- (2019) Chandan Kanta Das et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy
- (2019) Ji Wang et al. Journal of Hematology & Oncology
- Icariin induces apoptosis by suppressing autophagy in tamoxifen-resistant breast cancer cell line MCF-7/TAM
- (2019) Xia Cheng et al. Breast Cancer
- HDAC5-mediated deacetylation and nuclear localisation of SOX9 is critical for tamoxifen resistance in breast cancer
- (2019) Yue Xue et al. BRITISH JOURNAL OF CANCER
- Epigenetic silencing of SALL 2 confers tamoxifen resistance in breast cancer
- (2019) Liping Ye et al. EMBO Molecular Medicine
- Tumor‐associated macrophages secrete CC‐chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer
- (2019) Dongbo Li et al. CANCER SCIENCE
- Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer
- (2019) Annika Jögi et al. PLoS One
- Targeting Pin1 by All-Trans Retinoic Acid (ATRA) Overcomes Tamoxifen Resistance in Breast Cancer via Multifactorial Mechanisms
- (2019) Songyin Huang et al. Frontiers in Cell and Developmental Biology
- MTA1 is a novel regulator of autophagy that induces tamoxifen resistance in breast cancer cells
- (2018) Min-Ho Lee et al. Autophagy
- C-Cbl reverses HER2-mediated tamoxifen resistance in human breast cancer cells
- (2018) Wei Li et al. BMC CANCER
- KLF4 overcomes tamoxifen resistance by suppressing MAPK signaling pathway and predicts good prognosis in breast cancer
- (2018) Yunlu Jia et al. CELLULAR SIGNALLING
- BQ323636.1, a Novel Splice Variant to NCOR2, as a Predictor for Tamoxifen Resistant Breast Cancer
- (2018) Chun Gong et al. CLINICAL CANCER RESEARCH
- Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer
- (2018) Rasmi R. Mishra et al. CLINICAL CANCER RESEARCH
- Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer
- (2018) Gamze Guney Eskiler et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- N-desmethyl tamoxifen and quercetin-loaded multiwalled CNTs: A synergistic approach to overcome MDR in cancer cells
- (2018) Manish Kumar et al. Materials Science & Engineering C-Materials for Biological Applications
- IGF1R signaling drives antiestrogen resistance through PAK2/PIX activation in luminal breast cancer
- (2018) Yinghui Zhang et al. ONCOGENE
- Protein arginine N-methyltransferase�2 reverses tamoxifen resistance in breast cancer cells through suppression of ER-α36
- (2018) Yingying Shen et al. ONCOLOGY REPORTS
- Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1
- (2018) Yinghua Zhu et al. Nature Communications
- A review on the role of VEGF in Tamoxifen resistance
- (2018) Sepideh Mansouri et al. Anti-Cancer Agents in Medicinal Chemistry
- Oestrogen receptor-regulated glutathione S-transferase mu 3 expression attenuates hydrogen peroxide-induced cytotoxicity, which confers tamoxifen resistance on breast cancer cells
- (2018) Juo-Han Lin et al. BREAST CANCER RESEARCH AND TREATMENT
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- PTPN2 deficiency along with activation of nuclear Akt predict endocrine resistance in breast cancer
- (2018) Elin Karlsson et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Sphingosine kinase 1 activation by estrogen receptor α36 contributes to tamoxifen resistance in breast cancer
- (2018) Melissa A. Maczis et al. JOURNAL OF LIPID RESEARCH
- LEM4 confers tamoxifen resistance to breast cancer cells by activating cyclin D-CDK4/6-Rb and ERα pathway
- (2018) Ang Gao et al. Nature Communications
- Cold atmospheric plasma restores tamoxifen sensitivity in resistant MCF-7 breast cancer cell
- (2017) Seungyeon Lee et al. FREE RADICAL BIOLOGY AND MEDICINE
- GPER promotes tamoxifen-resistance in ER+ breast cancer cells by reduced Bim proteins through MAPK/Erk-TRIM2 signaling axis
- (2017) Heng Yin et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer
- (2017) Hee-Joo Choi et al. JNCI-Journal of the National Cancer Institute
- Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer
- (2017) Wan-xin Peng et al. Molecular Cancer
- IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer Cells
- (2017) Ali Vaziri-Gohar et al. MOLECULAR CANCER RESEARCH
- Embryonic transcription factor SOX9 drives breast cancer endocrine resistance
- (2017) Rinath Jeselsohn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Emerging Mechanisms in Initiating and Terminating Autophagy
- (2017) Manuela Antonioli et al. TRENDS IN BIOCHEMICAL SCIENCES
- Sensitization of tamoxifen-resistant breast cancer cells by Z-ligustilide through inhibiting autophagy and accumulating DNA damages
- (2017) Hongyi Qi et al. Oncotarget
- Aspirin regulation of c-myc and cyclinD1 proteins to overcome tamoxifen resistance in estrogen receptor-positive breast cancer cells
- (2017) Ran Cheng et al. Oncotarget
- The cyclin-like protein, SPY1, regulates the ERα and ERK1/2 pathways promoting tamoxifen resistance
- (2017) Rosa-Maria Ferraiuolo et al. Oncotarget
- Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance
- (2017) Jae Moon Gwak et al. Oncotarget
- Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer
- (2017) Hee-Joo Choi et al. JNCI-Journal of the National Cancer Institute
- Clinical Evidence on the Magnitude of Change in Growth Pathway Activity in Relation to Tamoxifen Resistance is Required
- (2017) Sepideh Mansouri et al. CURRENT CANCER DRUG TARGETS
- Co-treatment of LY294002 or MK-2206 with AZD5363 Attenuates AZD5363-induced Increase in the Level of Phosphorylated AKT
- (2016) AE-RAN CHOI et al. ANTICANCER RESEARCH
- Brachyury promotes tamoxifen resistance in breast cancer by targeting SIRT1
- (2016) Kaichun Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells
- (2016) Asona Lui et al. BMC CANCER
- Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
- (2016) Hope S. Rugo et al. JOURNAL OF CLINICAL ONCOLOGY
- Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
- (2016) Massimo Cristofanilli et al. LANCET ONCOLOGY
- Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
- (2016) Gabriel N. Hortobagyi et al. NEW ENGLAND JOURNAL OF MEDICINE
- The molecular mechanisms underlying the ERα-36-mediated signaling in breast cancer
- (2016) S Omarjee et al. ONCOGENE
- Combination treatment with proteasome inhibitors and antiestrogens has a synergistic effect mediated by p21WAF1 in estrogen receptor-positive breast cancer
- (2016) Marie Maynadier et al. ONCOLOGY REPORTS
- Dichloroacetate potentiates tamoxifen-induced cell death in breast cancer cells via downregulation of the epidermal growth factor receptor
- (2016) Sang Hyeok Woo et al. Oncotarget
- Current Management Strategies in Breast Cancer by Targeting Key Altered Molecular Players
- (2016) Shazia Ali et al. Frontiers in Oncology
- The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
- (2015) Richard S Finn et al. LANCET ONCOLOGY
- Differential effect of EGFR inhibitors on tamoxifen-resistant breast cancer cells
- (2015) SANGMIN KIM et al. ONCOLOGY REPORTS
- Expression and Localization of Estrogen Receptor in Human Breast Cancer and Its Clinical Significance
- (2014) Lv Li et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- LAMP3 is involved in tamoxifen resistance in breast cancer cells through the modulation of autophagy
- (2014) Anika Nagelkerke et al. ENDOCRINE-RELATED CANCER
- ERK/MAPK regulates ERRγ expression, transcriptional activity and receptor-mediated tamoxifen resistance in ER+ breast cancer
- (2014) Mary M. Heckler et al. FEBS Journal
- Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy
- (2014) D Elias et al. ONCOGENE
- Mechanisms associated with resistance to tamoxifen in estrogen receptor-positive breast cancer (Review)
- (2014) RUBÍ VIEDMA-RODRÍGUEZ et al. ONCOLOGY REPORTS
- Disruption of the ER-α36-EGFR/HER2 Positive Regulatory Loops Restores Tamoxifen Sensitivity in Tamoxifen Resistance Breast Cancer Cells
- (2014) Li Yin et al. PLoS One
- Pathway-Centric Integrative Analysis Identifies RRM2 as a Prognostic Marker in Breast Cancer Associated with Poor Survival and Tamoxifen Resistance
- (2014) Nagireddy Putluri et al. NEOPLASIA
- Estrogen Receptor-α Variant, ER-α36, is Involved in Tamoxifen Resistance and Estrogen Hypersensitivity
- (2013) XianTian Zhang et al. ENDOCRINOLOGY
- Resveratrol Sensitizes Tamoxifen in Antiestrogen-Resistant Breast Cancer Cells with Epithelial-Mesenchymal Transition Features
- (2013) Xiao-Peng Shi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- SIRT1 suppresses breast cancer growth through downregulation of the Bcl-2 protein
- (2013) SHOU-JEN KUO et al. ONCOLOGY REPORTS
- Efficacy of Histone Deacetylase and Estrogen Receptor Inhibition in Breast Cancer Cells Due to Concerted down Regulation of Akt
- (2013) Scott Thomas et al. PLoS One
- Individualization of Tamoxifen Treatment for Breast Carcinoma
- (2012) L Binkhorst et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Inhibition of the AKT/mTOR and erbB pathways by gefitinib, perifosine and analogs of gonadotropin-releasing hormone I and II to overcome tamoxifen resistance in breast cancer cells
- (2012) MARTIN BLOCK et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Alteration of Y-box binding protein-1 expression modifies the response to endocrine therapy in estrogen receptor-positive breast cancer
- (2011) Tokiko Ito et al. BREAST CANCER RESEARCH AND TREATMENT
- Autophagy and endocrine resistance in breast cancer
- (2011) Katherine L Cook et al. Expert Review of Anticancer Therapy
- Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin
- (2011) Jian-Hong Zuo et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression
- (2011) C Giordano et al. ONCOGENE
- High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagy
- (2011) Laura Gonzalez-Malerva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of angiogenesis by quercetin in tamoxifen-resistant breast cancer cells
- (2010) Soo Jin Oh et al. FOOD AND CHEMICAL TOXICOLOGY
- ER-α36, a Novel Variant of ER-α, Mediates Estrogen-Stimulated Proliferation of Endometrial Carcinoma Cells via the PKCδ/ERK Pathway
- (2010) Jing-Shan Tong et al. PLoS One
- The Critical Role of the Class III Histone Deacetylase SIRT1 in Cancer
- (2009) T. Liu et al. CANCER RESEARCH
- Regulation of Estrogenic Effects by Beclin 1 in Breast Cancer Cells
- (2008) S. John et al. CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started